Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by johnny007on Jan 04, 2018 8:45pm
106 Views
Post# 27285887

RE:Now...

RE:Now...I concur. Defintely needs the news now.

TA: It popped thre times (a charm), nice.
Now back below D 8ema T-Line and shall re-test 14c-16c range.
Then it all depends on news and such - if nothing comes, back to the floor.
Otherwise, with contracts + Milost, 200ma will be left below for 30c+.

What the heck is with management? They truly stretch semantics regarding their time base as disclosed in the PR and CC.

Personally I had one bid hit 16.5c re-adding. 
Now my bids sit at 14c - 15.5c, scaling back in on the way down before the news.

Last but not least - a golden cross is on the horizon: 50ma > 200ma maybe within 1-2 weeks.

Good luck.
Bullboard Posts